New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
June 13, 2014
08:05 EDTPLXProtalix CEO David Aviezer to retire this year
Protalix BioTherapeutics announced that David Aviezer, Ph.D., has decided to retire from his role as the company's President and CEO. He will retire this year upon the completion of a process to nominate his successor. In the meantime, Dr. Aviezer will continue serving as President and CEO and remains a member of the Board of Directors. The company's Board of Directors will appoint a committee to select a new CEO.
News For PLX From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
October 13, 2014
10:27 EDTPLXProtalix offers to produce ZMapp Ebola treatment, i24News reports
Israeli company Protalix offered its resources to help produce ZMapp, the experimental Ebola treatment from privately-held MAPP Pharmaceuticals that has been in short supply, i24News reported previously on September 7. The circulation of a report from unitedwithisrael.org, which points back to the prior i24 report on Protalix, may be contributing to the early session strength in in the stock, which is up 18% this morning, according to contacts. Reference Link

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use